跳至主要内容
临床试验/NCT01639053
NCT01639053进行中(未招募)不适用

U.S. Postapproval Study of Sientra Silicone Gel Breast Implants

Tiger Biosciences, LLC.1 个研究点 分布在 1 个国家目标入组 5,498 人开始时间: 2012年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
5,498
试验地点
1
主要终点
Long-term safety of Sientra Silicone Gel Breast Implants in women

研究概览

简要总结

This is a ten-year postapproval study to evaluate the long-term clinical performance of Sientra Silicone Gel Breast Implants under general conditions of use in the postmarket environment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
是

入选标准

  • •Genetic female with US residency
  • •Is at least 18 years old for primary or revision reconstruction or 22 years old for primary or revision augmentation
  • •Agrees to Sientra study requirements

排除标准

  • •Has an active infection anywhere in body
  • •Has active cancer without adequate treatment
  • •Currently pregnant or nursing
  • •Has any condition or diagnosis that, in the investigator's opinion, would negatively affect ability to complete study requirements
  • •If control participant, has undergone breast implant surgery with silicone gel-filled breast implants

研究组 & 干预措施

Gel Participants

Control Participants

结局指标

主要结局

Long-term safety of Sientra Silicone Gel Breast Implants in women

时间窗: 10-years

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验